James E Flynn Insider Trading for September 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James E Flynn.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of James E Flynn for September 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 26 2016 | VNDA | Vanda Pharmaceutic ... | Flynn James E | 10% Owner | Sell | S | 16.71 | 157,607 | 2,633,140 | 693,171 | 850.8 K to 693.2 K (-18.53 %) |
| Sep 26 2016 | VNDA | Vanda Pharmaceutic ... | Flynn James E | 10% Owner | Sell | S | 16.71 | 348,258 | 5,818,346 | 2,035,697 | 2.4 M to 2 M (-14.61 %) |
| Sep 26 2016 | VNDA | Vanda Pharmaceutic ... | Flynn James E | 10% Owner | Sell | S | 16.71 | 273,632 | 4,571,570 | 1,599,476 | 1.9 M to 1.6 M (-14.61 %) |
| Sep 26 2016 | VNDA | Vanda Pharmaceutic ... | Flynn James E | 10% Owner | Sell | S | 16.24 | 68,940 | 1,119,517 | 850,778 | 919.7 K to 850.8 K (-7.50 %) |
| Sep 26 2016 | VNDA | Vanda Pharmaceutic ... | Flynn James E | 10% Owner | Sell | S | 16.24 | 152,334 | 2,473,752 | 2,383,955 | 2.5 M to 2.4 M (-6.01 %) |
| Sep 26 2016 | VNDA | Vanda Pharmaceutic ... | Flynn James E | 10% Owner | Sell | S | 16.24 | 119,690 | 1,943,646 | 1,873,108 | 2 M to 1.9 M (-6.01 %) |
| Sep 19 2016 | VNDA | Vanda Pharmaceutic ... | Flynn James E | 10% Owner | Sell | S | 15.58 | 37,044 | 577,146 | 919,718 | 956.8 K to 919.7 K (-3.87 %) |
| Sep 19 2016 | VNDA | Vanda Pharmaceutic ... | Flynn James E | 10% Owner | Sell | S | 15.53 | 4,910 | 76,242 | 2,536,289 | 2.5 M to 2.5 M (-0.19 %) |
| Sep 19 2016 | VNDA | Vanda Pharmaceutic ... | Flynn James E | 10% Owner | Sell | S | 15.53 | 3,857 | 59,891 | 1,992,798 | 2 M to 2 M (-0.19 %) |
| Sep 19 2016 | VNDA | Vanda Pharmaceutic ... | Flynn James E | 10% Owner | Sell | S | 15.62 | 87,858 | 1,372,254 | 956,762 | 1 M to 956.8 K (-8.41 %) |
| Sep 19 2016 | VNDA | Vanda Pharmaceutic ... | Flynn James E | 10% Owner | Sell | S | 15.62 | 119,008 | 1,858,786 | 2,541,199 | 2.7 M to 2.5 M (-4.47 %) |
| Sep 19 2016 | VNDA | Vanda Pharmaceutic ... | Flynn James E | 10% Owner | Sell | S | 15.62 | 93,506 | 1,460,470 | 1,996,655 | 2.1 M to 2 M (-4.47 %) |
| Sep 19 2016 | VNDA | Vanda Pharmaceutic ... | Flynn James E | 10% Owner | Sell | S | 15.76 | 58,997 | 929,498 | 1,044,620 | 1.1 M to 1 M (-5.35 %) |
| Sep 19 2016 | VNDA | Vanda Pharmaceutic ... | Flynn James E | 10% Owner | Sell | S | 15.76 | 79,915 | 1,259,061 | 2,660,207 | 2.7 M to 2.7 M (-2.92 %) |
| Sep 19 2016 | VNDA | Vanda Pharmaceutic ... | Flynn James E | 10% Owner | Sell | S | 15.76 | 62,791 | 989,272 | 2,090,161 | 2.2 M to 2.1 M (-2.92 %) |
| Sep 14 2016 | NVLS | Nivalis Therapeuti ... | Flynn James E | Director | Option Exercise | A | 7.77 | 12,300 | 95,571 | 12,300 |